fxs_header_sponsor_anchor

Cryptocurrencies Price Prediction: Injective, Cryptos & Optimism – American Wrap 19 September

Injective price could rise 10% before shorts have a field day

Injective (INJ) price is trading with a bullish bias, outperforming many cryptocurrencies, including Bitcoin (BTC). The rally could continue but it all depends on how bulls play their hand. Meanwhile, experts advise that now could be the ideal time to invest in altcoins with the countdown to the Bitcoin halving continues.
Singapore’s central bank, Monetary Authority of Singapore (MAS), has issued its fourth enforcement report, outlining actions taken against firms like Three Arrows Capital, which did not have a management framework to identify, monitor and address cryptocurrency and digital asset investment risks.
 
Optimism, an Ethereum Layer 2 blockchain powered by OP, has started to distribute its token to eligible wallet addresses in the third round of its airdrop. The Layer 2 chain said late Monday via its official X account that there is no claims page, meaningthat eligible users will receive their share of OP tokens directly to their wallets.
 
 

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2025 FOREXSTREET S.L., All rights reserved.